SCHEMBL22561887

SCHEMBL22561887

C/C=C(C#N)\C(=N/n1nnc2ccccc21)N(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SLC9A1 P19634 3/20 0.36
POLB P06746 3/20 0.36
MAPK1 P28482 1/20 0.36
ATM Q13315 1/20 0.36
KEAP1 Q14145 1/20 0.36
GLA P06280 1/20 0.35
TSHR P16473 1/20 0.35
F2 P00734 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13604205 0.70 SLC9A1 (0.50) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL5694968 0.64 SLC9A1 (0.54) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL19071761 0.63 POLB (0.43) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL15040780 0.63 SLC9A1 (0.53) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL14596693 0.62 NPC1 (0.44) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL1259144 0.62 POLB (0.52) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL1829869 0.62 POLB (0.52) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL425007 0.62 KMT2A (0.61) ALDH1A1KDM4EKMT2AMAPTHTT
SCHEMBL28389006 0.62 POLB (0.47) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL19619922 0.61 SLC9A1 (0.50) SMN1; SMN2NPC1TP53RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191467-B1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS NOVARTIS AG (CH) 2020-10-21 EP disclosed